Metastatic MTLn3 and non-metastatic MTC adenocarcinoma cells can be differentiated by Pseudomonas aeruginosa

Summary Cancer patients are known to be highly susceptible to Pseudomonas aeruginosa (Pa) infection, but it remains unknown whether alterations at the tumor cell level can contribute to infection. This study explored how cellular changes associated with tumor metastasis influence Pa infection using...

Full description

Bibliographic Details
Main Authors: Matthew J. Novotny, Dacie R. Bridge, Karen H. Martin, Scott A. Weed, Robert B. Wysolmerski, Joan C. Olson
Format: Article
Language:English
Published: The Company of Biologists 2013-07-01
Series:Biology Open
Subjects:
Online Access:http://bio.biologists.org/content/2/9/891
_version_ 1818734464246743040
author Matthew J. Novotny
Dacie R. Bridge
Karen H. Martin
Scott A. Weed
Robert B. Wysolmerski
Joan C. Olson
author_facet Matthew J. Novotny
Dacie R. Bridge
Karen H. Martin
Scott A. Weed
Robert B. Wysolmerski
Joan C. Olson
author_sort Matthew J. Novotny
collection DOAJ
description Summary Cancer patients are known to be highly susceptible to Pseudomonas aeruginosa (Pa) infection, but it remains unknown whether alterations at the tumor cell level can contribute to infection. This study explored how cellular changes associated with tumor metastasis influence Pa infection using highly metastatic MTLn3 cells and non-metastatic MTC cells as cell culture models. MTLn3 cells were found to be more sensitive to Pa infection than MTC cells based on increased translocation of the type III secretion effector, ExoS, into MTLn3 cells. Subsequent studies found that higher levels of ExoS translocation into MTLn3 cells related to Pa entry and secretion of ExoS within MTLn3 cells, rather than conventional ExoS translocation by external Pa. ExoS includes both Rho GTPase activating protein (GAP) and ADP-ribosyltransferase (ADPRT) enzyme activities, and differences in MTLn3 and MTC cell responsiveness to ExoS were found to relate to the targeting of ExoS-GAP activity to Rho GTPases. MTLn3 cell migration is mediated by RhoA activation at the leading edge, and inhibition of RhoA activity decreased ExoS translocation into MTLn3 cells to levels similar to those of MTC cells. The ability of Pa to be internalized and transfer ExoS more efficiently in association with Rho activation during tumor metastasis confirms that alterations in cell migration that occur in conjunction with tumor metastasis contribute to Pa infection in cancer patients. This study also raises the possibility that Pa might serve as a biological tool for dissecting or detecting cellular alterations associated with tumor metastasis.
first_indexed 2024-12-18T00:05:46Z
format Article
id doaj.art-ec074df46c454e85a8a9632009d0ec68
institution Directory Open Access Journal
issn 2046-6390
language English
last_indexed 2024-12-18T00:05:46Z
publishDate 2013-07-01
publisher The Company of Biologists
record_format Article
series Biology Open
spelling doaj.art-ec074df46c454e85a8a9632009d0ec682022-12-21T21:27:48ZengThe Company of BiologistsBiology Open2046-63902013-07-012989190010.1242/bio.2013363220133632Metastatic MTLn3 and non-metastatic MTC adenocarcinoma cells can be differentiated by Pseudomonas aeruginosaMatthew J. Novotny0Dacie R. Bridge1Karen H. Martin2Scott A. Weed3Robert B. Wysolmerski4Joan C. Olson5 Department of Microbiology, Immunology and Cell Biology, West Virginia University Health Sciences Center, Morgantown, WV 26506-9177, USA Department of Microbiology, Immunology and Cell Biology, West Virginia University Health Sciences Center, Morgantown, WV 26506-9177, USA Department of Microbiology, Immunology and Cell Biology, West Virginia University Health Sciences Center, Morgantown, WV 26506-9177, USA Department of Neurobiology and Anatomy, West Virginia University Health Sciences Center, Morgantown, WV 26506-9128, USA Department of Neurobiology and Anatomy, West Virginia University Health Sciences Center, Morgantown, WV 26506-9128, USA Department of Microbiology, Immunology and Cell Biology, West Virginia University Health Sciences Center, Morgantown, WV 26506-9177, USA Summary Cancer patients are known to be highly susceptible to Pseudomonas aeruginosa (Pa) infection, but it remains unknown whether alterations at the tumor cell level can contribute to infection. This study explored how cellular changes associated with tumor metastasis influence Pa infection using highly metastatic MTLn3 cells and non-metastatic MTC cells as cell culture models. MTLn3 cells were found to be more sensitive to Pa infection than MTC cells based on increased translocation of the type III secretion effector, ExoS, into MTLn3 cells. Subsequent studies found that higher levels of ExoS translocation into MTLn3 cells related to Pa entry and secretion of ExoS within MTLn3 cells, rather than conventional ExoS translocation by external Pa. ExoS includes both Rho GTPase activating protein (GAP) and ADP-ribosyltransferase (ADPRT) enzyme activities, and differences in MTLn3 and MTC cell responsiveness to ExoS were found to relate to the targeting of ExoS-GAP activity to Rho GTPases. MTLn3 cell migration is mediated by RhoA activation at the leading edge, and inhibition of RhoA activity decreased ExoS translocation into MTLn3 cells to levels similar to those of MTC cells. The ability of Pa to be internalized and transfer ExoS more efficiently in association with Rho activation during tumor metastasis confirms that alterations in cell migration that occur in conjunction with tumor metastasis contribute to Pa infection in cancer patients. This study also raises the possibility that Pa might serve as a biological tool for dissecting or detecting cellular alterations associated with tumor metastasis.http://bio.biologists.org/content/2/9/891Tumor metastasisMTC and MTLn3 cellsPseudomonas aeruginosaRho GTPaseCell migration
spellingShingle Matthew J. Novotny
Dacie R. Bridge
Karen H. Martin
Scott A. Weed
Robert B. Wysolmerski
Joan C. Olson
Metastatic MTLn3 and non-metastatic MTC adenocarcinoma cells can be differentiated by Pseudomonas aeruginosa
Biology Open
Tumor metastasis
MTC and MTLn3 cells
Pseudomonas aeruginosa
Rho GTPase
Cell migration
title Metastatic MTLn3 and non-metastatic MTC adenocarcinoma cells can be differentiated by Pseudomonas aeruginosa
title_full Metastatic MTLn3 and non-metastatic MTC adenocarcinoma cells can be differentiated by Pseudomonas aeruginosa
title_fullStr Metastatic MTLn3 and non-metastatic MTC adenocarcinoma cells can be differentiated by Pseudomonas aeruginosa
title_full_unstemmed Metastatic MTLn3 and non-metastatic MTC adenocarcinoma cells can be differentiated by Pseudomonas aeruginosa
title_short Metastatic MTLn3 and non-metastatic MTC adenocarcinoma cells can be differentiated by Pseudomonas aeruginosa
title_sort metastatic mtln3 and non metastatic mtc adenocarcinoma cells can be differentiated by pseudomonas aeruginosa
topic Tumor metastasis
MTC and MTLn3 cells
Pseudomonas aeruginosa
Rho GTPase
Cell migration
url http://bio.biologists.org/content/2/9/891
work_keys_str_mv AT matthewjnovotny metastaticmtln3andnonmetastaticmtcadenocarcinomacellscanbedifferentiatedbypseudomonasaeruginosa
AT dacierbridge metastaticmtln3andnonmetastaticmtcadenocarcinomacellscanbedifferentiatedbypseudomonasaeruginosa
AT karenhmartin metastaticmtln3andnonmetastaticmtcadenocarcinomacellscanbedifferentiatedbypseudomonasaeruginosa
AT scottaweed metastaticmtln3andnonmetastaticmtcadenocarcinomacellscanbedifferentiatedbypseudomonasaeruginosa
AT robertbwysolmerski metastaticmtln3andnonmetastaticmtcadenocarcinomacellscanbedifferentiatedbypseudomonasaeruginosa
AT joancolson metastaticmtln3andnonmetastaticmtcadenocarcinomacellscanbedifferentiatedbypseudomonasaeruginosa